Merit Medical Systems Q3 2024 Adj. EPS $0.86 Beats $0.80 Estimate, Sales $339.800M Beat $334.621M Estimate
Portfolio Pulse from Benzinga Newsdesk
Merit Medical Systems reported Q3 2024 earnings per share of $0.86, surpassing the analyst estimate of $0.80. The company's sales reached $339.8 million, exceeding the expected $334.621 million and marking a 7.79% increase from the previous year.
October 30, 2024 | 8:18 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Merit Medical Systems reported better-than-expected Q3 2024 earnings and sales, with EPS of $0.86 beating estimates by 7.5% and sales of $339.8M surpassing expectations by 1.55%.
The positive earnings surprise and sales growth indicate strong performance, likely boosting investor confidence and positively impacting the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100